aureus in tertiary hospitals of Korea is 60-70%, which is higher than the reports from previous studies [ 6 , 7 ], while with the increase in use of vancomycin for the treatment of MRSA, there is an increasing trend in vancomycin resistant isolates, such as VISA and VRSA.
← all excerpts
The efficacy and safety of arbekacin and vancomycin for the treatment in skin and soft tissue MRSA infection: preliminary study.
1
—
—